Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services.
Founded in 1995, Oncodesign Services mission’ is to contribute to the discovery of innovative therapies with unmet medical needs, in particular in oncology, inflammation and infectious diseases. From target identification, hit-to-lead and lead optimization to IND filing,
Oncodesign Services support the R&D programs of customers globally (whether pharmaceutical companies, biotechs, public research institutions, etc.).
Oncodesign Services offers a full spectrum of services in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, in vivo/In vitro pharmacology (including humanized models). This continuum enables, either as stand-alone (SOLO) or as integrated (DRIVE) programs, the drug discovery of small molecule, molecular radiotherapy and biologicals entities.
As a pioneer in translational medicine to evaluate the efficacy of treatments, the company challenge relies on increasing throughput, minimizing timelines from bench to bedside while having a differential proposition of treatment for patients and therefore innovative science. For that, Oncodesign Services has been creating new technological pathways to find and select the best drug candidates.
Oncodesign Services has BSL1, BSL2 and BSL3 laboratories and all sites maintain the full AAALAC international accreditation for our animal care and use program.
Based in Dijon, France, in the heart of the university and hospital cluster, within the Paris-Saclay cluster and in Montreal, Canada, Oncodesign Services benefits from 15,000m² of fully equipped chemistry and biologic laboratories. Oncodesign Services has 230 employees in France, United Kingdom, Germany, Canada and the United States, with highly competent in discovery research and translational pharmacology.
Company Details
- Employees
- 190
- Founded
- -
- Address
- 20, Rue Jean Mazen, Bp 27627,france
- Phone
- +33 (0)3.80.78.82.60
- co****@****ign.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- oncodesign.com
- Keywords
- Kinase inhibitor Drug & Biomarker Discovery, Novel inflammatory target based drug discovery, Oncology advanced in vitro and in vivo pharmacology, Immunomodulation in oncology, DMPK/ADME, Medicinal chemistry, Bioanalysis, Translational Biomarkers, Biobanking, Biodecontamination/Biosafety, medicinal chemistry, drug discovery, drug analysis, Biopharma, Partnering, inflammatory diseases, infectious diseases, vitro assay development, vivo models.
- HQ
- Dijon Cedex
Oncodesign Services Questions
Oncodesign Services's helpline number is +33 (0)3.80.78.82.60
Oncodesign Services's website is oncodesign.com
Oncodesign Services's LinkedIn profile is https://www.linkedin.com/company/oncodesign
Oncodesign Services has
190 employees.
View email and phone details for 190
employees at Oncodesign Services.
Oncodesign Services's industry is
Biotechnology Research
Oncodesign Services's top competitors are
Innate Pharma,
Ose Immunotherapeutics,
Transgene,
Phaxiam Therapeutics,
Cellectis,
Abivax,
Bioaster,
Valneva,
Oncodesign Precision Medicine - Opm,
Maat Pharma.
Oncodesign Services's support email address is contact@oncodesign.com
Oncodesign Services's categories are Biotechnology Research
Oncodesign Services's founding year is 1995
